NICE publishes final guidance for EYLEA for visual impairment due to diabetic macular oedema
Bayer HealthCare is pleased to announce that NICE has made the final recommendation for EYLEA® (aflibercept solution for injection) for the treatment of visual impairment due to diabetic...